Press Releases

GlobeNewswire, Inc.

Generated second quarter 2026 revenue of $64.8 million with record high Commercial IoT subscriber activations.

GlobeNewswire, Inc.

PARIS and NEW YORK , Aug. 06, 2026 (GLOBE NEWSWIRE) -- Pasqal Holding SAS ("Pasqal"), a global leader in neutral-atom quantum computing, today announced that its joint registration statement on Form F-4 (the "Registration Statement") with...

GlobeNewswire, Inc.

Commercial preparations for brepocitinib in dermatomyositis (DM) are progressing well and on track for launch by the end of September 2026; topline data from Phase 3 study in non-infectious uveitis (NIU) expected in the second half of calendar...

ECB - European Central Bank

Prepared by Malin Andersson, Alina Bobasu, Lorena Saiz and Stefania Scrofani 1 Introduction Economic uncertainty has increasingly become a defining feature of the macroeconomic environment.

GlobeNewswire, Inc.

LOS ANGELES, Aug. 04, 2026 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL), today announced financial results for the second quarter ended June 30, 2026. “I believe the first half of 2026 will prove to be the most consequential period in...

GlobeNewswire, Inc.

Second Quarter Highlights Strong sequential shipment growth, driven by increased silicon metal volumes in EMEA and the U.S. Reporting second quarter adjusted EBITDA of $13.1 million Ended the quarter with total cash of $93.2 million and net debt...

GlobeNewswire, Inc.

TORONTO, Aug. 04, 2026 (GLOBE NEWSWIRE) -- International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) today released its financial and operational results and related management’s discussion and analysis (MD&A) for...

EIN Presswire

The new MUSASHI JAPAN France Red Store adds a red interior concept to the brand’s growing Paris retail network.

GlobeNewswire, Inc.

Appoints Julien Perrier Chief Commercial Officer Completes previously authorized $100 million share repurchase program; Board authorizes additional $50 million under repurchase program Reaffirms 2026 revenue guidance RADNOR, Pa., Aug. 04, 2026...

GlobeNewswire, Inc.

-- U.S. launch of IMCIVREE® (setmelanotide) for acquired hypothalamic obesity (HO) starts strong with more than 400 patient start forms since FDA approval as of June 30, 2026 -- -- Second quarter 2026 net product revenue from global sales of...

GlobeNewswire, Inc.

Carbios reaffirms its commitment to building the Longlaville plant.

GlobeNewswire, Inc.

• Q2’26 Total Net Revenue of $343 Million, Up 14% YoY • Record Quarterly Total SUBLOCADE® Net Revenue of $253 Million in Q2'26, Up 21% YoY • Record Quarterly GAAP Net Income of $122 Million and Record Non-GAAP Net Income of $142 Million in Q2'26 •...

GlobeNewswire, Inc.

$119.2 million in 2Q VYJUVEK global revenue and $965.9 million since launch Multiple clinical data readouts in 2H 2026 On track for VYJUVEK launches in Spain and Italy later this year Strong balance sheet, ending the quarter with $1.1 billion in...

GlobeNewswire, Inc.

ROCKVILLE, Md., Aug. 02, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of...

EIN Presswire

The Business Research Company's Orthopedic Imaging Equipment Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035 LONDON, GREATER LONDON, UNITED KINGDOM, August 21, 2026 /⁨EINPresswire.com⁩/ -- "The orthopedic imaging equipment...

GlobeNewswire, Inc.

NEW YORK, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Coordinated Development Across Four Core Markets—the United Kingdom, France, Romania, and Germany—Marks a New Stage of International Growth Brantone Veylor recently announced the launch of a new phase in...

GlobeNewswire, Inc.

Press release 30 July 2026 - N° 17 SCOR announces the availability of its 2026 Interim Financial Report SCOR (“SCOR” or the “Company”) announces the availability and the filing with the French Autorité des marchés financiers of its Interim...

GlobeNewswire, Inc.

PARIS, FRANCE, 21 AUGUST 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today it has completed the acquisition of Kartos Therapeutics, a clinical-stage biopharmaceutical company adding late-stage MDM2 inhibitor navtemadlin in Phase III...

GlobeNewswire, Inc.

Cash and cash equivalents at €166.1 million and €67.8 million in short-term deposits2 as at June 30, 2026 Daix (France), New York City (New York, United States), July 30, 2026 – Update to Press Release Dated July 29, 2026. The Company wishes to...

GlobeNewswire, Inc.

NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today...